Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > PHAR Pharming Group > Detailed Quotes

PHAR Pharming Group

Watchlist
13.450
+0.080+0.60%
Close  02/01 16:00 ET
13.4500.0000.00%
Post Mkt Price 02/01 16:00 ET
High
14.163
Open
13.500
Turnover
114.89K
Low
13.450
Pre Close
13.370
Volume
8.47K
Market Cap
877.50M
P/E(TTM)
29.89
52wk High
15.000
Shares
65.24M
P/E(Static)
58.48
52wk Low
6.100
Float Cap
847.83M
Bid/Ask %
0.00%
Historical High
21.990
Shs Float
63.04M
Volume Ratio
3.72
Historical Low
6.100
Dividend TTM
--
Div Yield TTM
--
P/B
4.38
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.01%
Amplitude
5.33%
Avg Price
13.566
Lot Size
1
Float Cap
847.83M
Bid/Ask %
0.00%
Historical High
21.990
Shs Float
63.04M
Volume Ratio
3.72
Historical Low
6.100
Dividend TTM
--
P/B
4.38
Dividend LFY
--
Turnover Ratio
0.01%
Amplitude
5.33%
Avg Price
13.566
Lot Size
1
Price Forecast

News

Comment

No Data

Company Overview More
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following geographical segments: the United States, Europe, and Rest of the World. The company was founded on November 11, 1988 and is headquartered in Leiden, the Netherlands.
CEO: Dr. Sijmen (Simon) de Vries, M.D.
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist